NCT05731908View on ClinicalTrials.gov

A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

April 13, 2023

Study Completion Date

April 13, 2023

Conditions
Liver DiseasesHealthy
Interventions
DRUG

BI 690517

BI 690517

Trial Locations (2)

32808

Omega Research Orlando, LLC, Orlando

32809

Orlando Clinical Research Center, Orlando

Sponsors
All Listed Sponsors
collaborator

IQVIA global CRO

UNKNOWN

lead

Boehringer Ingelheim

INDUSTRY

NCT05731908 - A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems | Biotech Hunter | Biotech Hunter